<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD011552-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD011552-sec-0022"></div> <div class="table" id="CD011552-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings for the main comparison.</span>Â <span class="table-title">Cryotherapy versus control for preventing oral mucositis in adults receiving fluorouracilâbased treatment for solid cancers</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Cryotherapy versus control for preventing oral mucositis in adults receiving fluorouracilâbased treatment for solid cancers</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> adults** with solid cancers receiving fluorouracilâbased cancer treatment<br><b>Setting:</b> hospital<br><b>Intervention:</b> cryotherapy<br><b>Comparison:</b> control (no treatment or routine care) </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>No of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with control</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with cryotherapy</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral mucositis (any)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>728 per 1000</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>444 per 1000<br> (379 to 524) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.61<br> (0.52 to 0.72) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>444<br> (5 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br> MODERATE <sup>1</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral cryotherapy reduced the risk of developing oral mucositis by 39% (95% CI 28% to 48%). We would need to treat 4 people (95% CI 3 to 5 people) with oral cryotherapy to prevent 1 additional person from developing oral mucositis </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral mucositis (moderate + severe)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>530 per 1000</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>276 per 1000<br> (217 to 344) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.52<br> (0.41 to 0.65) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>444<br> (5 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br> MODERATE <sup>1</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral cryotherapy reduced the risk of developing moderate to severe oral mucositis by 48% (95% CI 35% to 59%). We would need to treat 4 people (95% CI 4 to 6 people) with oral cryotherapy to prevent 1 additional person from developing moderate to severe oral mucositis </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral mucositis (severe)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>300 per 1000</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>120 per 1000<br> (81 to 183) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.40<br> (0.27 to 0.61) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>444<br> (5 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br> MODERATE <sup>1</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral cryotherapy reduced the risk of severe oral mucositis by 60% (95% CI 39% to 73%). We would need to treat 6 people (95% CI 5 to 9 people) with oral cryotherapy to prevent 1 additional person from developing severe oral mucositis </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interruptions to cancer treatment</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>400 per 1000</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>176 per 1000<br> (80 to 380) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.44<br> (0.20 to 0.95) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>80<br> (1 RCT) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br> VERY LOW <sup>2 3 4</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral cryotherapy reduced the risk of treatment interruption by 56% (95% CI 5% to 80%). We would need to treat 5 people (95% CI 4 to 50 people) with oral cryotherapy to prevent 1 additional person from having a treatment interruption </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral pain (1 to 5 scale: 1 = never, 2 = 1 day of week, 3 = 2 to 3 days of week, 4 = most of week, 5 = 7 days of week) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean oral pain (1 to 5 scale) was 3.64</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean oral pain (1 to 5 scale) in the cryotherapy group was 1.93 lower (2.37 to 1.49 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>80<br> (1 RCT) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br> VERY LOW <sup>2 3 4</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The duration of oral pain experienced was less in the oral cryotherapy group (Additional <a href="#CD011552-tbl-0003">Table 1</a>) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quality of life</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>No studies assessed this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Normalcy of diet (days of total parenteral nutrition)</p> </td> <td align="left" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>No studies assessed this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Duration of hospitalisation (days)</p> </td> <td align="left" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>No studies assessed this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><br><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> <br><b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate quality:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low quality:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br><b>Very low quality:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> All 5 studies at high risk of performance and detection bias </p> <p><sup>2</sup> Single study at high risk of performance and detection bias </p> <p><sup>3</sup> Low sample size and wide confidence interval </p> <p><sup>4</sup> Indirect due to single study in 1 setting (in terms of country, healthcare system, and participants potentially differing from other countries) </p> <p>** There were no studies conducted on children</p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD011552-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Cryotherapy versus control for preventing oral mucositis in adults receiving highâdose melphalanâbased treatment prior to haematopoietic stem cell transplantation for haematological cancers</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Cryotherapy versus control for preventing oral mucositis in adults receiving highâdose melphalanâbased treatment prior to haematopoietic stem cell transplantation for haematological cancers</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> adults** with haematological cancers receiving highâdose melphalanâbased treatment prior to haematopoietic stem cell transplantation<br><b>Setting:</b> hospital<br><b>Intervention:</b> cryotherapy<br><b>Comparison:</b> control (no treatment or routine care) </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>No of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with control</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with cryotherapy</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral mucositis (any)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>824 per 1000</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>486 per 1000<br> (289 to 833) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.59<br> (0.35 to 1.01) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>270<br> (5 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br> LOW <sup>1 2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral cryotherapy appears to reduce the risk of developing oral mucositis. However, there is great uncertainty about our estimate, and there is an extremely small chance of a 1% increase in the risk of developing oral mucositis compared to control. The point estimate suggests a 41% reduction in the risk of developing oral mucositis, with the confidence interval ranging from a 65% reduction to a 1% increase in risk. We would need to treat 3 people with oral cryotherapy to prevent 1 additional person from developing oral mucositis, with the confidence interval ranging from 2 people (to prevent 1 additional oral mucositis case) to 111 people to cause 1 additional person to develop oral mucositis </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral mucositis (moderate + severe)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>679 per 1000</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>292 per 1000<br> (115 to 741) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.43<br> (0.17 to 1.09) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>270<br> (5 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br> LOW <sup>1 2</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral cryotherapy appears to reduce the risk of developing moderate to severe oral mucositis. However, there is great uncertainty about our estimate, and there is a very small chance of a 9% increase in the risk of developing moderate to severe oral mucositis compared to control. The point estimate suggests a 57% reduction in the risk of developing moderate to severe oral mucositis, with the confidence interval ranging from an 83% reduction to a 9% increase in risk. We would need to treat 3 people with oral cryotherapy to prevent 1 additional person from developing moderate to severe oral mucositis, with the confidence interval ranging from 2 people (to prevent 1 additional moderate to severe oral mucositis case) to 17 people to cause 1 additional person to develop moderate to severe oral mucositis </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral mucositis (severe)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>427 per 1000</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>162 per 1000<br> (85 to 308) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.38<br> (0.20 to 0.72) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>270<br> (5 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br> MODERATE <sup>1</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral cryotherapy reduced the risk of developing severe oral mucositis by 62% (95% CI 28% to 80%). We would need to treat 4 people (95% CI 3 to 9 people) with oral cryotherapy to prevent 1 additional person from developing severe oral mucositis </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interruptions to cancer treatment</p> </td> <td align="left" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>No studies assessed this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral pain on a 0 (no pain) to 10 (maximum pain) scale</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The weighted mean oral pain (0 to 10 scale) was 2.13</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean oral pain (0 to 10 scale) in the cryotherapy group was 1.5 lower (2.11 to 0.89 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>85<br> (2 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br> LOW <sup>3 4</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral cryotherapy reduced oral pain by 70% although the clinical importance of a 1.5 pointâreduction on a 0 to 10 scale is questionable </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quality of life</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>1 study assessed this outcome but the data are currently unavailable as the study report and analysis have not yet been completed </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Normalcy of diet (days of total parenteral nutrition â TPN)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean number of days of TPN was 7</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean number of days of TPN in the intervention group was 2.18 days fewer (4.33 to 0.03 fewer) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>78<br> (1 RCT) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br> VERY LOW <sup>5 6 7</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Oral cryotherapy reduced the duration of TPN by 2.18 days. There was some additional very low quality evidence, from a single small study at high risk of bias, reporting only median, range and P value, that oral cryotherapy reduced the number of days of TPN (Additional <a href="#CD011552-tbl-0003">Table 1</a>) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Duration of hospitalisation (days)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean duration of hospitalisation (days) was 0</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean duration of hospitalisation (days) in the intervention group was 1.39 undefined fewer (2.97 fewer to 0.19 more) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>123<br> (2 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br> LOW <sup>3 4</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There is insufficient evidence to show that oral cryotherapy reduces the duration of hospitalisation. This is supported by additional very low quality evidence, from a single small study at high risk of bias, reporting only median, range and P value, that there is insufficient evidence to show a reduction in this outcome (Additional <a href="#CD011552-tbl-0003">Table 1</a>) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><br><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>TPN:</b> total parenteral nutrition </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> <br><b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate quality:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low quality:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br><b>Very low quality:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> All 5 studies at risk of performance and detection bias, with 1 study at added risk of attrition bias </p> <p><sup>2</sup> The I<sup>2</sup> value indicates that a considerable amount (&gt; 90%) of the variability in effect estimates is due to heterogeneity rather than chance </p> <p><sup>3</sup> Both studies at high risk of performance and detection bias </p> <p><sup>4</sup> Low sample size from 2 small studies </p> <p><sup>5</sup> Single study at high risk of performance and detection bias </p> <p><sup>6</sup> Low sample size and wide confidence interval </p> <p><sup>7</sup> Indirect due to single study in 1 setting (in terms of country, healthcare system, and participants potentially differing from other countries) </p> <p>** There were no studies conducted on children</p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
